Analysis Article • Jul 14
Have your own idea? Try our Stock Screener
U.K. (FTSE) Clinical Research and Equipment Industry Analysis
UpdatedJul 28, 2026
DataAggregated Company Financials
Companies7
- 7D-1.2%
- 3M-6.2%
- 1Y-45.8%
- YTDn/a
Over the last 7 days, the Clinical Research and Equipment industry has dropped 1.2%, driven by a pullback from Oxford Nanopore Technologies of 1.4%. Meanwhile, hVIVO actually outperformed within the industry, gaining 9.1% in the last week. Overall the industry is down 46% in 12 months. Earnings are forecast to grow by 51% annually.
Industry Valuation and Performance
Has the U.K. Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 28 Jul 2026 | UK£1.3b | UK£323.1m | -UK£164,731,254.00 | 1117.3x | -7.6x | 3.9x |
| Thu, 25 Jun 2026 | UK£1.3b | UK£323.0m | -UK£166,018,254.00 | 1265.7x | -8.1x | 4.2x |
| Sat, 23 May 2026 | UK£1.5b | UK£318.9m | -UK£167,635,254.00 | n/a | -9x | 4.7x |
| Mon, 20 Apr 2026 | UK£1.5b | UK£318.2m | -UK£167,469,254.00 | n/a | -8.8x | 4.6x |
| Wed, 18 Mar 2026 | UK£1.4b | UK£324.0m | -UK£161,423,254.00 | 10.2x | -8.9x | 4.4x |
| Fri, 13 Feb 2026 | UK£1.6b | UK£304.6m | -UK£159,441,254.00 | 11.5x | -9.8x | 5.1x |
| Sun, 11 Jan 2026 | UK£1.6b | UK£304.6m | -UK£159,441,254.00 | 8x | -9.9x | 5.2x |
| Tue, 09 Dec 2025 | UK£1.5b | UK£304.3m | -UK£160,776,254.00 | 6.2x | -9.1x | 4.8x |
| Thu, 06 Nov 2025 | UK£1.5b | UK£304.3m | -UK£163,156,254.00 | 8.4x | -9.4x | 5x |
| Sat, 04 Oct 2025 | UK£1.7b | UK£304.0m | -UK£163,375,352.00 | 9.4x | -10.6x | 5.7x |
| Mon, 01 Sep 2025 | UK£2.0b | UK£291.9m | -UK£160,968,352.00 | 6.3x | -12.2x | 6.7x |
| Wed, 30 Jul 2025 | UK£2.2b | UK£291.9m | -UK£160,968,352.00 | 6.5x | -13.6x | 7.5x |
| Fri, 27 Jun 2025 | UK£1.7b | UK£319.0m | -UK£190,372,994.20 | 7.4x | -8.8x | 5.3x |
| Sun, 25 May 2025 | UK£1.7b | UK£319.4m | -UK£190,818,893.50 | 10.9x | -8.7x | 5.2x |
| Tue, 22 Apr 2025 | UK£1.6b | UK£314.9m | -UK£185,639,007.85 | 6.3x | -8.5x | 5x |
| Thu, 20 Mar 2025 | UK£1.6b | UK£315.5m | -UK£186,044,479.55 | 6x | -8.4x | 4.9x |
| Sat, 15 Feb 2025 | UK£1.9b | UK£306.5m | -UK£195,193,006.08 | 7x | -9.6x | 6.1x |
| Mon, 13 Jan 2025 | UK£1.9b | UK£307.7m | -UK£196,115,709.60 | 7.1x | -9.7x | 6.2x |
| Wed, 11 Dec 2024 | UK£2.0b | UK£306.1m | -UK£194,860,303.92 | 8.7x | -10.4x | 6.6x |
| Fri, 08 Nov 2024 | UK£1.9b | UK£304.8m | -UK£192,758,078.08 | 10.7x | -9.8x | 6.2x |
| Sun, 06 Oct 2024 | UK£2.1b | UK£304.3m | -UK£192,222,280.30 | 10.8x | -10.7x | 6.8x |
| Tue, 03 Sep 2024 | UK£1.8b | UK£295.7m | -UK£188,349,503.70 | 12.4x | -9.7x | 6.2x |
| Thu, 01 Aug 2024 | UK£1.8b | UK£295.4m | -UK£189,847,017.33 | 12.6x | -9.4x | 6.1x |
| Sat, 29 Jun 2024 | UK£1.5b | UK£296.0m | -UK£190,325,313.69 | 11.4x | -7.8x | 5x |
| Mon, 27 May 2024 | UK£1.7b | UK£295.6m | -UK£189,818,792.31 | 11.3x | -8.7x | 5.6x |
| Wed, 24 Apr 2024 | UK£1.5b | UK£317.7m | -UK£178,571,906.75 | 11.9x | -8.7x | 4.9x |
| Fri, 22 Mar 2024 | UK£1.9b | UK£295.8m | -UK£213,156,250.81 | 7353.6x | -8.7x | 6.3x |
| Sun, 18 Feb 2024 | UK£2.1b | UK£286.0m | -UK£189,371,602.11 | 6964.1x | -11x | 7.3x |
| Tue, 16 Jan 2024 | UK£2.8b | UK£449.9m | -UK£173,972,209.00 | 64.6x | -16.3x | 6.3x |
| Thu, 14 Dec 2023 | UK£2.9b | UK£453.0m | -UK£170,859,631.00 | 51.8x | -17x | 6.4x |
| Sat, 11 Nov 2023 | UK£3.0b | UK£456.4m | -UK£169,493,058.00 | 47.3x | -17.7x | 6.6x |
| Mon, 09 Oct 2023 | UK£2.9b | UK£458.5m | -UK£165,463,545.00 | 54.3x | -17.5x | 6.3x |
| Wed, 06 Sep 2023 | UK£3.2b | UK£476.5m | -UK£126,799,419.00 | 70.6x | -25.3x | 6.7x |
| Fri, 04 Aug 2023 | UK£3.3b | UK£476.6m | -UK£124,776,985.00 | 69.6x | -26.7x | 7x |
Price to Earnings Ratio
-26.7x
Current Industry PE
- Investors are pessimistic on the British Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 5.7x is higher than the industry's current PS ratio of 3.9x.
Past Earnings Growth
- The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
- Revenues have also declined 12% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Comparison
How does U.K. Clinical Research and Equipment compare with similar industries?
| GB Market | 2.33% | |
| Healthcare | 3.45% | |
| Life Sciences | -1.15% | |
| Clinical Research and Equipment | -1.15% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| HVO hVIVO | UK£0.072 | 9.1% +UK£4.1m | -28.0% | PS1x | |
| FAB Fusion Antibodies | UK£0.11 | 2.4% +UK£312.6k | 10.3% | PS8.4x |